Insider · CIK 0001766070
James Treco
Files at TNXP (Tonix Pharmaceuticals Holding Corp.). First filing Aug 20, 2025, latest Aug 20, 2025.
In brief
James Treco files SEC Form 4 as director at TNXP (Tonix Pharmaceuticals Holding Corp.). Since Aug 20, 2025, James Treco has reported 1 open-market buy worth $9,000 and 0 open-market sells worth $0, the latest filed on Aug 20, 2025.
A track record needs three past buys with six months of prices behind them; James Treco has 0, so none is measured yet.
The newest scored trade: bought $9,000 of TNXP on Aug 20, 2025, filed Aug 20, 2025, scored 31 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNXP: Tonix Pharmaceuticals Holding Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Tonix Pharmaceuticals Holding Corp. | $9,000 250 shares | - | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +22,700 | $0.00 | $0 | 22,700 | May 14, 2026 |
| Aug 20, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | POpen-market purchase Common Stock, par value $0.001 | +250 | $36.00 | $9,000 | 250 | Aug 20, 2025 |
| May 13, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +10,000 | $0.00 | $0 | 10,000 | May 15, 2025 |
Questions about James Treco
Answered from the filings on this page, as of the latest one.
Is James Treco buying or selling?
Not in the last 12 months. James Treco's latest open-market trade on SEC Form 4 was bought $9,000 of TNXP on Aug 20, 2025.
How did James Treco's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Treco has 0.
Where does James Treco file Form 4?
James Treco has filed Form 4 at TNXP (Tonix Pharmaceuticals Holding Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.